Magnetic resonance imaging (MRI) guidance for coronary interventions offers potential advantages over conventional xray angiography. Advantages include the use of nonionizing radiation, combined assessment of anatomy and function, and three-dimensional assessment of the coronary arteries leading to the myocardium. These advantages have prompted a series of recent studies in this field. Real-time coronary MR angiography, with low-dose catheter-directed intraarterial (IA) infusion of contrast media, has achieved in-plane spatial resolution as low as 0.8 ϫ 0.8 mm 2 and temporal resolution as short as 130 msec per image. Catheter-based IA injection of contrast agent has proven useful in the collection of multislice and three-dimensional images, not only for coronary intervention guidance, but also in the assessment of regional myocardial perfusion fed by the affected vessel. Actively visible guidewires and guiding catheters, based on the loopless antenna concept, have been effectively used to negotiate tortuous coronary vessels during catheterization, permitting placement of coronary angioplasty balloon catheters. Passive tracking approaches have been used to image contrast agentfilled coronary catheters and to place susceptibility-based endovascular stents. Although the field is in its infancy, these early results demonstrate the feasibility for performing MRIguided coronary interventions. Although further methodological and technical developments are required before these methods become clinically applicable, we anticipate that MRI someday will be included in the armamentarium of techniques used to diagnose and treat coronary artery disease. RECENT ADVANCES IN MR methodology and instrumentation have allowed the rigorous exploitation of the new field of "interventional MRI," i.e., the methodology of performing diagnostic and, primarily, therapeutic interventions under MRI guidance (1-3). Despite generalized acceptance of magnetic resonance angiography (MRA) as a diagnostic tool, performing therapeutic interventions under MRI guidance has not yet been translated successfully into the clinical realm. X-ray angiography is the current reference standard for guiding coronary artery intervention such as balloon angioplasty or stent placement. Coronary angiography performed under x-ray guidance provides outstanding submillimeter spatial and subsecond temporal resolution for guiding vascular interventions (4).
RECENT ADVANCES IN MR methodology and instrumentation have allowed the rigorous exploitation of the new field of "interventional MRI," i.e., the methodology of performing diagnostic and, primarily, therapeutic interventions under MRI guidance (1) (2) (3) . Despite generalized acceptance of magnetic resonance angiography (MRA) as a diagnostic tool, performing therapeutic interventions under MRI guidance has not yet been translated successfully into the clinical realm. X-ray angiography is the current reference standard for guiding coronary artery intervention such as balloon angioplasty or stent placement. Coronary angiography performed under x-ray guidance provides outstanding submillimeter spatial and subsecond temporal resolution for guiding vascular interventions (4) .
Despite the indisputable role of x-ray fluoroscopy, MRI guidance for endovascular procedures offers several important potential advantages over conventional x-ray guidance: 1) Because of its intrinsic sensitivity to flow and soft-tissue contrast, MRI allows the combined assessment of vessel morphology and morphology and function of myocardial tissue. This provides the ability to detect changes in cardiac function following coronary interventions; 2) MRI permits the selection of threedimensional volumes and arbitrary scan-planes, which might depict the desired anatomy for the procedure, without the need to manually reposition the patient or the imaging instrument; 3) MRI avoids ionizing radiation exposure to the patient and the medical team performing the procedures; and 4) MRI does not use iodinated contrast agents, thereby avoiding the risk of nephrotoxicity and allergic reactions.
MRI-guided vascular procedures are still early in their development. Most studies have been performed in animals, with little published experience in human beings. In animal models, published applications of MRI-guided endovascular interventions include inferior vena cava filter placement (5, 6) , percutaneous transluminal angioplasty (PTA) of the aorta (7-9) and renal arteries (10, 11) , stent placement within the iliac artery (12, 13) and aorta (13, 14) , coronary angiography (15, 16) , and carotid artery aneurysm embolization (17) . In human subjects, MRI-guided hemodialysis arteriovenous and loop graft fistulography (18) and iliac artery stent placement (19) have also been performed. Serfaty et al (16) first demonstrated the feasibility of coronary MRA using catheter-directed intraarterial (IA) injections of gadolinium (Gd)-based contrast agent.
The benefits of MRI might allow it to be used as a comprehensive modality to diagnose and treat coronary artery disease in a single session. This combined approach offers the advantage of allowing the incorporation and integration of different diagnostic or therapeutic procedures within the same session. For example, early assessment of myocardial perfusion of the reclaimed myocardium after a percutaneous transluminal coronary angioplasty (PTCA) may identify regions of "no-reflow" (20 -22) ; contrast-enhanced MRI can be used to assess regional myocardial perfusion (23, 24) , including transmural perfusion gradients (25) . Even more intriguing is the possibility of assessing atherosclerotic plaque with intracoronary MRI (26 -28) to guide treatment decisions that may address the issue of high rates of restenosis after PTCA (29) . The demonstration of MR-guided gene therapy delivery (30) is yet another illustration of the potential of MRI in interventional cardiology. The above examples are a partial list of the possible diagnostic or therapeutic approaches that can be included in an MR-based comprehensive method of cardiac patient management.
Current MRI-guided coronary interventions that have been demonstrated in animals include real-time angiography (16, 31, 32) , catheterization (33) (34) (35) , balloon angioplasty (34) , and stent placement (36) . In this review, we examine approaches towards performing realtime coronary MRA and coronary interventions.
TECHNIQUES AND METHODS OF IMPLEMENTATION
To guide coronary interventions, MR methods must have the following prerequisites: 1) sufficient volume of coverage for the targeted tortuous and branched coronary vasculature; 2) high acquisition speed; 3) high vessel-to-tissue contrast; 4) diagnostic quality images with high in-plane spatial resolution; and 5) suitable MR-compatible and visible interventional instrumentation. Satisfying these requirements is challenging, especially when compared with the gold standard of x-ray guidance. However, several MRI techniques (33-36) can be used individually or combined together to address these challenges.
Three major phases can be identified during a coronary intervention that dictate the development of specialized MR methodology: 1) anatomical imaging for identification and characterization of the vascular lesion; 2) guidance and accurate positioning of the interventional instrumentation to the targeted area; and 3) assessment of the pathophysiology of the targeted tissue (the latter is pertinent to both the initial screening of the disease and for assessment of the procedure). Thus far, the major focus of MR-guided coronary interventions has been on the development of real-time coronary MRA techniques and on the monitoring of MRcompatible vascular interventional devices.
Contrast-Enhanced Coronary MRA with IA Infusion of MR Contrast Agents
Currently, the primary method of achieving real-time coronary MRA is catheter-directed localized IA delivery of low dose Gd-based MR contrast agent (16, 31, 37) . This contrast delivery is coupled with fast imaging pulse sequences, which are highly T1-weighted and saturate the background tissue's unwanted signal to generate high coronary signal enhancement. This approach is similar to x-ray angiography, and the rationale for its use is supported by several benefits.
Catheter-directed delivery allows the conservation of contrast agent, thereby facilitating multiple or longduration injections without exceeding doses used in routine standard of care. Multiple and long-duration injections are important during coronary procedures to define vascular anatomy, confirm intraluminal position of endovascular devices, and to document change in vascular anatomy following an intervention. Conventional intravenous (IV) injections use larger amounts of contrast agent, have longer transit periods, and are prone to dispersion. Catheter-directed injections, however, use smaller volumes of dilute contrast agent to generate comparable coronary artery-myocardial contrast-to-noise ratios (CNR). An additional benefit is that the low dose of Gd results in less background tissue enhancement, while enhancing only the artery of interest. Because adjacent vascular beds remain suppressed, there is clearer local artery depiction. Catheter-directed IA infusion of Gd-based contrast agents has been investigated using a variety of coronary MRA protocols, such as short-duration (16, 37) and long-duration (31) real-time imaging of projections (16), singleslab (31, 32, 37) , multiple planes (31), three-dimensional volumes (32) , and first-pass perfusion (31) .
Real-Time Two-Dimensional Coronary MRA with IA Contrast Agent Infusion
When a rapid vascular roadmap is desired (e.g., to monitor the advancement of an interventional device), then fast two-dimensional sequences are the methods of choice (16, (33) (34) (35) 37) . Standard thin-slice two-dimensional sequences suffice when the targeted blood vessels are located within a well-defined imaging plane, such as in the peripheral circulation. However, for the tortuous and continuously moving coronary vessels, thick-slab two-dimensional imaging is more appropriate. This approach has been adopted either with nonslice-selective (16, 33, 34) or with 2-20-cm thick-slab imaging (31, 35) . Most often identified in the literature as "projection MRA," thick-slab imaging offers certain important features suitable for real-time coronary imaging. When the projection plane of the non-slice-selective version (16) or the orientation of the thick slab (31, 37) are appropriately prescribed, the entire portion of a tortuous vessel can be imaged with a single acquisition. In addition, the thick slab can be set to include the vessel without electrocardiographic (ECG)-triggering, thereby ensuring the presence of the targeted vessel independent of the heart phase. Moreover, these volume approaches are appropriate for imaging the preshaped catheters and devices used for coronary catheterization.
Since projection (i.e., thick-slab) MRA collects signals from a large volume, the background signal can be overwhelmingly higher than that of a contrast-en-hanced vessel. Therefore, over a large volume, it is of paramount importance to retain the high contrast-enhanced blood signal while suppressing the background signal. Since the vessels are contrast-enhanced due to T1 shortening, T1-weighted sequences, which suppress the long T1 species and retain the short T1 species, are the most appropriate. This can be achieved using a conventional steady-state gradient-echo (GRE) sequence with a large flip angle, as has been previously reported (16) , or with magnetization-prepared sequences (31, 32, 35) . Figure 1 shows representative results from the first demonstration of real-time coronary MRA with IA infused contrast-agent enhancement (16) in dogs. In these studies, a catheter placed in the left coronary artery, under x-ray fluoroscopy, was used to locally deliver Gd-based contrast agent. A fast spoiled GRE sequence (TR/TE/excitation angle ϭ 4.4 msec/1.4 msec/90°; FOV ϭ 32 ϫ 16 cm; matrix ϭ 256 ϫ 128; imaging time ϭ 300 msec per image) was used to generate heavy T1-weighted contrast to suppress background signal and enhance the contrast agent-perfused vessel. As these results show, the use of a 90°n on-slice-selective excitation angle generates efficient background signal suppression.
An alternative approach for imaging IA-enhanced coronary vessels is based on heavily T1-weighted magnetization preparation pulse sequences (31, 32, 35) . Currently, three T1-weighted magnetization-driven steady-state preparation schemes have been used for real-time coronary MRA with IA injection of Gd-based contrast agents. Figure 2 summarizes these pulse sequences. With these sequences, suppression of relatively long T1 species (T1 Ͼ 150 msec, including fat and myocardium) is achieved with preparation pulses, Figure 2 . Diagrams of the magnetization-prepared pulse sequences currently used to generate T1-weighting for real-time coronary MRA. A: The SR sequence implemented for cardiactriggered multislice acquisitions. The initial non-slice-selective saturation pulse ensures that the magnetization evolution is the same for all slices. Cardiac triggering was used for acquisition of the same slice of the multislice set at the same cardiac phase. The SR sequence was also used for single-plane nontriggered acquisition. B: The IR sequence used for twodimensional real-time projection imaging. The non-slice-selective inversion is followed by an inversion recovery period (TI) and spoiling gradients, and then by the acquisition of a segment of the k-space (i.e., N lines) with a standard spoiled GRE acquisition scheme. C: The ECG-triggered three-dimensional MR angiographic sequence with 100 non-slice-selective preparation pulses (for background suppression) initiated after the R wave. At the end of the preparation pulses, a non-sliceselective inversion pulse is applied, followed by a TI and the acquisition of N phase-encoding lines with a spoiled GRE.
which precede the acquisition. With these sequences, T1-weighting is achieved with non-slice-selective saturation pulses before the acquisition of an entire image ( Fig. 2A) , inversion pulses (Fig. 2B) , or the combination of inversion and steady-state magnetization suppression pulse trains (Fig. 2C) . Then, acquisition can be performed with much smaller flip angles, so the effects of the slice profile are greatly reduced, while tissue radiofrequency (RF) power deposition remains low. With these sequences, the excitation pulses during image acquisition act in accord with the preparation pulses to maintain or augment the vessel-to-tissue contrast. Figures 3 and 4 show results of real-time coronary MRA during IA infusion of Gd-based agent using the saturation recovery (SR) and inversion recovery (IR) preparation schemes. With SR and IR, the T1-weighting and background suppression are created with non-section-selective saturation or inversion pulses. The main difference between SR and IR is that with IR the inversion time (TI) can be adjusted to achieve wider nulling of the long T1 species. Since with SR there is no magnetization nulling point, the evolution delay between the saturation pulse and the acquisition must be kept as short as possible. Although SR is inherently faster than IR, the penalty is less efficient saturation. Both SR and IR magnetization preparation schemes are useful for suppressing background signal and improving CNR between blood and background tissue (32, 37, 38) . When using IR preparation in each cardiac cycle, only background tissues that have a rather narrow T1 range will be suppressed. Green et al (32) addressed this limitation by combining both steady-state and IR preparation techniques ( Fig. 3 ) to uniformly suppress background tissues over a wider range of inversion times, while retaining high blood signal as in non-ECG-triggered imaging.
For contrast-enhanced MRA, spoiled GRE sequences have been predominantly used. An alternative approach is true fast imaging with steady-state precession (True-FISP), which generates coronary images with higher CNR and signal-to-noise ratio (SNR) in comparison to spoiled GRE (35, 39) . Using a slab thickness of 5 cm, comparisons (39) demonstrated that the mean coronary artery SNR for True-FISP was 10.0 Ϯ 1.2 and for conventional GRE imaging it was 5.2 Ϯ 0.8. Mean coronary artery CNR with True-FISP was 7.1 Ϯ 0.7, while with conventional GRE imaging sequence it was 3.5 Ϯ 0.7. These represent SNR and CNR increases of approximately a factor of two using the True-FISP sequence (P Ͻ 0.05).
Optimization of IA Contrast Agent Injections
Gd-based MR contrast agents shorten both the longitudinal relaxation time (T1) and the apparent transverse relaxation time (T2*). While shortening of T1 results in the desired MR signal enhancement, the concomitant reduction of T2* results in signal loss with techniques such as GRE and echo planar imaging (EPI) pulse sequences, which are fast, but are also T2*-sensitive. The competing T1 and T2* shortening mechanisms result in an optimal range of Gd concentrations, which maximizes the blood signal. Determination of the optimal concentration of dilute Gd for IA MRA has been addressed theoretically (40, 41) and experimentally, on static (16, 42) and dynamic (43) phantoms, and in vivo (16, 40, 43, 44) . The key points of these studies are that: 1) satisfactory vascular depiction occurs over a relatively broad range of arterial Gd concentrations with little practical difference in vessel enhancement, or SNR between 6% (30 mM) and 9% (45 mM) (16, 40, 44) ; and 2) optimal arterial Gd concentration depends on the specific imaging parameters. Figure 5 , which shows initial studies by Serfaty et al (16) for the calibration of the optimal dose for use with a 90°excitation-pulse sequence, clearly depicts that high SNR can be achieved over a broad range of Gd concentrations. It clearly shows the wide range of optimal Gd-based contrast agent concentrations for optimal contrast with the 90°excitation-angle projection MRA. Comparison of the left circumflex (LCx) coronary artery SNR for the different injection schemes, shown in Fig. 6 , demonstrates statistically significant differences in mean SNR between each of the three injection rates: 0.5 mL/second, 1.0 mL/second, and 1.5 mL/second; P Ͻ 0.05). The mean SNRs using the 6% and 9% diluted contrast agent were significantly greater than that with 3% (15 mM) diluted contrast agent (P Ͻ 0.05). There was no statistical difference in mean SNR between 6% and 9% diluted contrast agent (P Ͼ 0.05). Figure 7 illustrates the vessel SNR and the vessel-to-tissue CNR of the LCx at five consecutive angiographic sessions performed with IA infusion of Gd-based contrast agent on three dogs using the SR-prepared GRE sequence. In each session, 1.5 mmol Gd was infused and the sessions were separated by two to three minutes. The SNR (P ϭ 0.60) and CNR (P ϭ 0.94) remained essentially unchanged over all five consecutive angiographic sessions, demonstrating that multiple low-dose, slow infusions of Gd-based MR contrast agent can be performed without compromise of the vessel CNR. This is a critical point, since vascular interventions require that multiple consecutive coronary injections be performed without compromising vessel CNR.
Conventional extracellular MR Gd chelates diffuse and accumulate to the extravascular space, thereby reducing the vessel-to-tissue contrast. In principle, with IA contrast agent delivery, the vessel contrast can be maintained if the low-dose agent delivery is slow enough to allow for sufficient tissue contrast-agent clearance (16, 31, 32, 37) . Moreover, if the localized contrast-agent delivery is appropriately adjusted, then IA enhancement can be maintained for long durations (Ϸ2.5 minutes) and multiple consecutive infusions (31) . The panel of images in Fig. 8A demonstrates that the contrast-enhanced LCx is consistently and clearly seen over a period of 2.3 minutes. To better appreciate and quantify the contrast enhancement of the coronary vessels, signal intensity (SI) time curves were generated from these angiographic studies (Fig. 8B) . The SI time curves were extracted from ROIs prescribed to include the enhanced coronary vessel (ROI-1), myocardium (ROI-2), and chest wall (45) . The vessel-containing ROI-1 was made large enough to include the coronary artery at all time frames, to account for the motion of the heart. The vessel SI (SI VESSEL ) was then calculated by removing the estimated contribution of tissue to the SI of ROI-1. Based on the assumption that the relative vessel and tissue contributions in ROI-1 are the same in every frame of the time series, the vessel SI was calculated by subtracting a tissue contribution equal to the area-normalized SI of the adjunct tissue ROI-2, weighted with the relative area of the tissue in the ROI-1. The vessel weighted time curve for LCx, with the tissue contribution removed (based on the SI of ROI-2), shows a fast contrast enhancement following the initialization of the Gd infusion that remains fairly constant (0.94 Ϯ 0.14 arbitrary units [au] ) over the period of agent delivery, (spanning about 2.3 minutes; horizontal gray bar), and then recovers after discontinuation. In contrast, the myocardial ROI-2 shows delayed onset and progressively increased enhancement, since it receives and accumulates Gd at later frames after circulation. The chest fat demonstrates virtually no signal changes. 
Multislice and Three-Dimensional Coronary MRA With IA Infusion of Gd-based Contrast Agents
MRI offers the capability, unmatched by any other modality, to image three-dimensional volumes or two-dimensional projections in any arbitrary orientation. This capability may provide better visualization of tortuous and branched vasculature and facilitate guidance of complex interventions. Both approaches have been successfully employed with IA infusion of Gd-based contrast agent in the coronary artery. In contrast, with x-ray angiography, changing the orientation of the image projection plane requires repositioning of the x-ray device and additional contrast agent injections.
When assessment of multiple views or simple volumetric reconstruction is desired, then oblique orientation multislice approaches can be more time efficient. Dynamic coronary MRA of different projections of the same vessel or multiple vessels has been shown by repetitively collecting multislice frames (31) . Figure 9 shows a representative example from a study where different slices of a multislice frame were prescribed in oblique orientations, to depict the LCx, the left anterior descending (LAD), and obtuse marginals (OM). Using an SR-prepared GRE sequence with cardiac gating, each slice of a multislice frame was collected at the same cardiac phase.
Three-dimensional sequences are suitable choices when high spatial resolution and multiplanar volumetric reconstructions are desired. Applications of these sequences may include the detailed mapping of the targeted vascular tree, or the identification and characterization of a stenotic coronary lesion. Threedimensional contrast enhanced coronary MRA with IA infusion has been demonstrated on dogs (32) . Figure 10 shows a scout image (Fig. 10A ) and the maximum intensity projection image (Fig. 10B ) from a contrast-enhanced three-dimensional MRA collected during IA infusion of Gd-based contrast agent. Excellent suppression of the background tissue signal throughout the imaging volume was achieved with the combined steady-state and IR magnetization preparation scheme, as shown in Fig. 10B . Contrast enhancement was performed by infusing 12 mL of 6% (30 mM) diluted contrast agent during a 20 second period and achieving a mean SNR in the LCx of 3.90 Ϯ 0.05 (SD). Although the equivalent of only 0.7 mL of undiluted contrast agent was used for vessel enhancement, the LCx is clearly depicted, with sharply defined vessel boundary. Moreover, two circumflex marginal arteries are also visible. Figure 11 shows another example of a three-dimensional coronary MRA with IA Gd, comparing a two-dimensional dynamic coronary MRA (Fig. 11A ) spatially-matched with partitions from the contrast-enhanced (Fig. 11B) and nonenhanced (Fig. 11C) three-dimensional coronary MRA. In these studies, three-dimensional imaging was performed using a segmented IR sequence and contrast enhancement with continuous infusion of low concentration Gd (50 mM) with slow rate (0.2 mL/second). With this protocol, the SNR of the LCx was 4.2 Ϯ 0.1. In these images, a double bifurcation originating from the LCx is clearly seen in the threedimensional partition and to a lesser extent in the two-dimensional dynamic image (resolution 1.5 ϫ 1.5 mm 2 ). These preliminary studies demonstrate that multislice two-dimensional and three-dimensional coronary MRA with IA infusion of contrast agent can provide a more detailed assessment of the coronary tree. Moreover, because they require a low dose of Gdbased agent, background contrast during an interventional procedure is not significantly affected. This feature is useful in monitoring coronary interventions when three-dimensional imaging or multislice proto- 2), shows a fast contrast enhancement following the initialization of the Gd-DTPA infusion, which remains fairly constant (0.94 Ϯ 0.14 au) over the period of agent delivery spanning about 2.3 minutes (horizontal gray bar), and then recovers after discontinuation. The myocardial ROI shows delayed onset and progressively increased enhancement, since it receives and accumulates Gd-DTPA at later frames. The chest wall demonstrates virtually no signal enhancement. Data from references 31 and 45. cols may be interleaved with single-plane real-time two-dimensional imaging.
Myocardial First-Pass Perfusion Assessment with IA Contrast Injection
An important benefit offered by MRI, which is not available for x-ray angiography, is the ability to assess changes in end-organ function, such as regional myocardial perfusion (23) and myocardial viability (46 -48) . These techniques offer alternative methods to characterize the functional significance of coronary artery disease, rather than relying on coronary anatomy alone. During MR guided coronary interventions, such diagnostic protocols can be performed before, during, and after the intervention to assess the progress of the procedure and to potentially alter the anticipated treatment.
Although not yet proven, regional myocardial perfusion assessment with first- pass Gd-based contrast agent may be improved when IA injections are used, because the local delivery provides a more compact input bolus. Moreover, with low-dose IA contrast agent infusion, first-pass studies can be interleaved with angiographic imaging to assess the progress of the procedure. Figure 12 shows results from a first-pass study performed with IA injection of Gd into the left main coronary artery (31) . The multislice frame in Fig. 12A demonstrates a 270% peak enhancement in the anterior, anteroseptal, and apical posterior myocardium. In contrast, minor enhancement of no more than 25% is observed in the posterolateral and lateral walls; this enhancement appears later since these territories are perfused with Gd at subsequent recirculation. The above regional perfusion pattern is consistent with the dominant left coronary artery system that preferentially feeds the anterior, anteroseptal, and anteroposterior walls of the canine heart. In contrast, during peripheral injection of Gd via the femoral vein (Fig. 12C) , all myocardial territories demonstrate similar enhancement. The signal intensity time curves clearly show that with IA infusion, recirculation and dispersion of the contrast agent with a wide range of transit times is avoided, and the anterior wall shows distinct agent clearance beneficial for regional perfusion quantification. Notably, with IA infusion, myocardial tissue enhancement occurs first, followed by the right ventricle, and then the left ventricle (Fig.  12F ). However, with peripheral infusion, the enhancement of the ventricular cavities precedes that of the myocardium (Fig. 12H) .
Performance of MR-guided Coronary Procedures
Currently, three implementations for visualizing endovascular instrumentation during coronary interventions have been exploited on animal models. Those methods employ active device visualization, based on the loopless antenna (33, 34) ; passive visualization of susceptibility artifacts (36) ; or a combination of active and passive visualization using enhancement of contrast agent-filled catheters (34, 35) .
Active Visualization of Devices with Loopless Antennas in Coronary Interventions
This approach is based on the loopless antenna concept (49) , and is used to visualize both the guidewire and the guiding catheters (33, 34) . The loopless antenna is a coaxial cable with an extended inner conductor, which can be placed inside vessels (49) . Figure 13A shows a photograph of the loopless antenna guidewire and an example of a guiding catheter used for coronary catheterization. When operating as a receive coil, the loopless antenna can provide images of the immediately adjacent tissues with a high signal from within the vessel or the catheter lumen, and can be detected as a bright line (50) . For endovascular MR-guided interventions, both the inner conductor and the shield of the loopless antenna are composed of nitinol, a nonmagnetic alloy. In addition to suitable MR properties, nitinol-based loopless antennas offer flexibility and maneuverability similar to standard guidewires. These guidewires and guiding catheters provided the mechanical properties necessary for performing MR-guided coronary interventions with the interventionist residing next to the MR scanner gantry opening (Fig. 13B) . The loopless antenna implement has been used to visualize both a guidewire and a guiding catheter (33, 34) or only the guidewire, while a passive approach was used for the catheter (35) .
In addition to the guidewire, an actively visualized guiding catheter was also demonstrated, constructed by attaching a nitinol loopless antenna (Surgi-Vision, Inc., Columbia, MD) to the wall of a standard Bentson guiding catheter (Cook, Bloomington, IN). A thin and flexible copper wire was attached to the extended inner wire, 3 mm after the junction between the shield and the extended inner wire, and was wrapped around the distal part of the guiding catheter in order to maintain the natural flexibility of the guiding catheter. This implementation was studied on dogs. One loopless antenna was used as the guidewire and the other was used as the guiding catheter, each connected to its own tuning and matching circuit, em- ploying two different receiver channels of the scanner. Thus, when the MRI-guidewire and the MRIguiding catheter were used simultaneously for reception of the MR signal, both could be visualized in a single projection image (Fig. 14) .
Passive Visualization of Devices in Coronary Interventions
Passive visualization, i.e., using the magnetic resonance properties of material rather than an RF coil, has also been demonstrated in coronary interventions. In these studies, passive visualization was based on the T1-shortening of a Gd-filled catheter (35) or an angioplasty balloon (34) , and on the susceptibility artifacts generated by a stent (36) . In one study of coronary catheterization through the femoral artery (35) , the loopless antenna guidewire (Intercept, Surgi-Vision) was inserted into a Judkins coronary catheter. For visualization of the catheter, its residual annular lumen was filled with 4% (20 mM) Gd-based contrast agent to permit imaging with a T1-weighted sequence. Similarly, after its placement inside a targeted coronary artery, the balloon of a PTCA catheter was inflated with dilute Gd and imaged with the T1-weighted non-slice-selective projection MRA sequence described above (34) . Spuentrup et al (36) used the susceptibility artifacts of a commercial nitinol guidewire and of a stainless steel stent to visualize these interventional devices and guide coronary artery stent placement in swine. Specifically, a commercial stainless steel coronary stent (2.5-5 mm diameter, 1.5 cm length, and 0.09 mm wall thickness) was mounted on either a 4-mm or a 3-mm balloon catheter. In these studies, the large signal void of the stainless stent was tracked, rather than the catheter itself. Figure 14 shows representative results from an MRguided coronary intervention using the dual loopless antenna-based guidewire and guiding catheter approach, as tested on a dog model with a carotid artery cutdown access using two imaging protocols (34) . The first protocol was based on using two pulse sequences, a three-dimensional angiography roadmap image of the thoracic aorta as the background image, and a nonslice-selective GRE (TR/TE/flip angle ϭ 5 msec/1.3 msec/7°; matrix ϭ 256 ϫ 128; FOV ϭ 30 ϫ 15 cm; and acquisition time ϭ 320 msec per image) for tracking the device. Tracking images of the MRI-guiding catheter collected with the latter pulse sequence were superimposed onto the roadmap image for navigation in the vessel. An alternative imaging approach, which used a single pulse sequence to visualize the anatomy of the targeted area and for tracking the MRI-guiding catheter and MRI guidewire, was evaluated in these studies. Specifically, a non-slice-selective GRE (TR/TE/flip angle ϭ 5 msec/1.3 msec/10°, matrix ϭ 256 ϫ 128 matrix, FOV ϭ 40 ϫ 20 cm, update time ϭ 320 msec) proved efficient in providing anatomical information and tracking information to assess the position of the loopless antennas. As shown in Fig. 14 , it was possible to image the guidewire, the MRI-guiding catheter, and the organs, with the heart (appearing bright), the lungs (dark), and the abdomen (bright) easily differentiated.
Performance of MR-Guided Coronary Catheterizations
In a subsequent study, the same actively visualized loopless antenna-based guidewire and guiding catheter were modified to include a coronary balloon angioplasty catheter (34) . After catheterization, the MRI guidewire was inserted in the guiding catheter together with the balloon catheter (charger, length ϭ 50 cm, catheter internal diameter ϭ 0.36 mm, balloon length ϭ 2 cm, balloon diameter ϭ 2 mm; Cordis, Miami, FL). After the catheters were placed successively in the left anterior coronary artery or the circumflex artery, the balloon was inflated with diluted Gd. Figure 14E shows results from the placement and inflation of the balloon angioplasty catheter in the LCx coronary artery. A susceptibility artifact induced by a magnetic ring in the middle of the balloon allowed localization of the balloon catheter (34) .
The combined passive catheter and active guidewire approach was demonstrated in pigs for catheterization via the femoral artery (35) . Figure 15 shows representative images from this study. Under real-time MRI guidance, the active guidewire and catheter were advanced from the femoral artery into the left or right coronary arteries of pigs. As the devices were advanced, predetermined oblique anatomic orientations and loca- tions were interactively selected, based on device position. Once the coronary ostium was engaged, two-dimensional projection coronary MRA was used with IA infusion of Gd-based contrast agent.
The catheter was tracked using a standard two-dimensional IR-prepared GRE sequence (TR/TE/flip angle ϭ 2.3 msec/1.15 msec/20°; TI ϭ 50 msec, FOV ϭ 206 ϫ 300 mm 2 , acquisition matrix ϭ 74 ϫ 256, slice thickness ϭ 30 mm). To achieve an effective temporal resolution of seven frames per second, a sliding window technique (51) was used which acquired 42 new lines during each acquisition period. The guidewire was detected as a dark susceptibility artifact using two-dimensional TrueFISP (TR/TE/flip angle ϭ 2.9 msec/ 1.45 msec/70°, FOV ϭ 206 ϫ 300 mm 2 , matrix ϭ 70 ϫ 128, slice thickness ϭ 30 mm). The detection of this dark artifact was enhanced by the bright signal from the background tissue adjacent to the guidewire. The external phased array coil was used to provide anatomical background. With a sliding window technique, the TrueFISP sequence yielded an effective temporal resolution of nine frames per second by acquiring 40 new lines each acquisition period. Figure 16 shows representative coronary images obtained with IA infusion of contrast agent after successful MR-guided catheterization, demonstrating the clear depiction of selectively enhanced coronary vessels.
CHALLENGES LIMITING PRACTICAL APPLICATION
Recent studies have demonstrated the feasibility of performing MRI-guided coronary interventions. These studies include: 1) real-time two-dimensional and three-dimensional coronary angiography, with intraarterial catheter-directed infusion of Gd-based contrast media; 2) coronary artery catheterization, using loopless antenna-based guidewires and guiding catheters or passive visualization; and 3) the deployment of coronary artery balloon catheters and stents. Although these early feasibility studies show that MRI can be used to guide coronary interventions, they also demonstrate significant limitations and technical challenges that must be addressed prior to implementation in humans.
From a pulse sequence point of view, the most important element for monitoring coronary catheterizations are high speed MR pulse sequences that achieve high spatial resolution. Because catheter-directed IA delivery of Gd-based MR contrast agents boosts local vessel signal, this technique is vital towards achieving this goal. In the majority of the studies performed so far, IA injections were performed using fast GRE sequences for a near real-time coronary MRA.
IA injections offer several advantages over conventional IV administration of contrast agent. First, local delivery avoids systemic contrast material dispersion, as in the case of IV administration. Second, IA injections do not require a prestudy dose timing test bolus (52) or other complex scheme (53) (54) (55) to synchronize the arrival of contrast agent with image acquisition. Instead of waiting for first-pass arterial passage of Gd, there is immediate contrast agent delivery into the vessel of interest (16, 31, 32, 37) . Third, low dose IA injections can be used to assess first-pass regional myocardial perfusion (31) before, during, or after a coronary intervention. Unlike IV injections, only small contrast agent boluses are required for each perfusion measurement. The IA infusion offers a more compact and immediate input bolus necessary for quantification of perfusion. Fourth, IA infusions can separate overlapping vascular structures from the targeted artery, similar to x-ray coronary injections.
While IA injection of Gd-based contrast agents is a promising tool for coronary interventions, there are several limitations, primarily associated with the safety for human use. There is no FDA approval for catheterbased Gd injections. Although the studies presented were performed on animal models, IA Gd injections have been safely performed in humans with underlying renal insufficiency for x-ray digital subtraction angiography (DSA) (56 -59) . Finally, substantial research is required confirm the diagnostic accuracy for detecting and grading stenosis with Gd-based MR contrast agents.
For real-time coronary MRA with IA infusion of Gd, several variants of the GRE pulse sequences have been evaluated, including non-slice-selective with 90°exci-tation flip angle (16) , magnetization preparation GRE (31,37), or TrueFISP. With complete k-space acquisition and subsequent image reconstruction, fast GRE sequences provide acquisition rates of 3.5 frames per second (16) ; faster rates of 7.5 images per second can be achieved with reduced spatial resolution (31) . Sliding window reconstruction techniques can be employed to improve temporal and/or spatial resolution (32, 35, 37) . However, higher refresh rates and finer spatial resolution are needed to improve the quality of lesion identification and device tracking for access to distal vessels and branches. Continued potential improvements in SNR and spatiotemporal resolution might be achieved by adopting sequences with ultrashort repetition times (Ͻ1.5 msec), reduced field of views imaging for guidewire and MRI guiding catheters visualization (60) , intravascular coils (49), higher imaging fields, parallel imaging (61), and echo-planar imaging (62) .
Further research is required to determine the optimal method for coronary catheterization. Active coronary catheterization approaches use the loopless antenna for signal detection (33, 34, 36) . These active approaches present a safety concern due to tissue heating from switching magnetic field gradients. Methods to reduce this heating include plastic-coated nitinol coaxial cables, decoupling, and balun circuits (63) . Active visualization requires multiple receiver channels for simultaneous visualization of instruments and vessel anatomy. Although the commercial active guidewire employed has been approved by the FDA for peripheral plaque imaging in humans, further studies maybe required to characterize their use in the coronary vessels. While a passive approach permitted successful coronary stent placement (36) , visualization of devices, especially the nitinol guidewire, was extremely limited. It is unclear if the trade-off of potentially improved safety from reduced guidewire heating is worth the cost of poor visualization. Although a combination of passive and catheter visualization might offer some benefits (36) , improving the methods used to track devices is undoubtedly a fertile area for future research.
Because the field of MR-guided coronary interventions is at a very early stage, the studies performed so far do not accurately simulate the conditions encountered on human interventions. First, there has been no pathologic assessment of potential valvular or vascular injury caused by the procedure. Second, in the published studies, animals often underwent x-ray coronary angiography prior to MRI-guided catheterization, which may have favorably influenced the success of MRI procedures. Finally, none of the studies were performed on animals with coronary lesions. The best in-plane resolution, 0.8 mm, is insufficient to visualize stenoses in distal and branch arteries.
When considering human MRI-guided coronary interventions, improved real-time image reconstruction systems and display systems need to be developed. The image reconstruction and display systems available on current commercial MRI scanners are still impractical for human coronary interventions. One study reported a delay of approximately 100 msec between the acquisition of an image and its display on the in-room monitor (35) . This lag time was not the rate-limiting step in this study, because the image acquisition time was 280 msec (34) . However, as faster MR techniques are developed, with image acquisition times of 50 msec, it will become necessary to reduce this lag time proportionally. To be clinically practical, future reconstruction systems should be able to provide simultaneous realtime reconstruction of 15-30 images per second for each channel/slice, which is equivalent to four channels for a reconstruction rate of 60 -120 images per second.
Another poorly addressed issue associated with MRIguided interventions is the acoustic noise of the MR scanner, which impacts the patients, and the medical personnel. Although earplugs or headphones are helpful, communication between the interventionist, scan operator, and patient still needs to be improved. To this end, in-room consoles to control the scanner would also be a desirable feature to add to the list of necessary hardware improvements.
MRI-guided coronary artery interventions remain a very challenging endeavor. Given the superb temporal and spatial resolution of x-ray fluoroscopy and its safety profile, the unique benefits of MRI guidance needs to be carefully exploited to benefit patient care. We anticipate that MRI may shift the characterization of a coronary lesion from purely "anatomical" information to "combined anatomical and functional" information, using a single-modality during the same imaging/treatment session. MRI provides the unique opportunity to characterize a vascular lesion as well as its consequences on the myocardium. For example, using firstpass Gd injections under basal or pharmacologically induced vasodilation conditions, the perfusion of the downstream muscle can be assessed before and after an intervention. The characterization of the tissue physiological condition, rather than only the existence of a lesion itself, is the subject of analysis in an evergrowing body of literature (48, 64, 65) . Such information, not available with x-ray angiography, may allow assessment of important consequences of a stenotic lesion, e.g., the perfusion and oxygenation of the tissue.
Other MR technologies, such as lesion characterization with intravascular coils, further enhances the armamentarium of MR methodologies. MRI guidewires, such as the loopless antennas demonstrated in recent works (33, 34) , can be used to receive high signal from the lesion and allow characterization of the atherosclerotic plaque components and the differentiation of lipids, fibrosis, and calcification (36,66 -69) . Furthermore, in vivo monitoring of catheter-based vascular gene delivery in the myocardium may be directed as previously shown (30) . Similarly, interventions that require direct injection of therapeutic agents into the myocardium, such as injection of VEGF in the myocardium (70), or cardiac radiofrequency ablation (71), can be visualized more efficiently.
Finally, intravascular contrast agents can be considered, in comparison to extracellular agents. Advantages include greater T1 relaxivity, higher concentrations within the blood pool, and a reduction of extravasation into the myocardium in comparison to extracellular agents. A principal disadvantage, however, is that with intravascular contrast agents, blood signal remains enhanced for a relatively long period of time. While this is an advantage for routine coronary MRA, prolonged blood pool enhancement may not be desirable for coronary MRA interventions in which multiple injections of contrast agent with rapid intravascular clearance are required.
We conclude that the development of coronary interventional MRI should be shaped by the unique properties of MRI and may not necessarily simply mimic x-ray guided coronary procedures. With further research, we think that MRI-guided coronary intervention has the potential to increase the future treatment options for patients with coronary artery disease.
